covishield

India is considering to give an approval for mixing of Russia’s Sputnik V and Oxford–AstraZeneca’s Covishield, which is being manufactured by Pune-based SII, for Covid-19 vaccination. Once allowed, the people will be free to choose the…

Deaths from COVID-19 were surging across Africa in June when 100,000 doses of the Pfizer-BioNTech vaccine arrived in Chad. The delivery seemed proof that the United Nations-backed program to immunize the world could get the most desirable…

Coronavirus News LIVE Updates: India recorded a meager drop in weekly Covid-19 infections since the peak of the second wave as the case count in the current week from July 19-25 fell by just around 1.2% as compared with the previous seven…

Rs 9,725.15 crore – that is the vaccination bill for India so far. The Centre has spent Rs 8,071.09 crore to buy vaccines and remaining about Rs 1,654.06 crore on operational costs for administering the vaccines, as per details shared by…

Bharat Biotech is all set to commence its trial for the second dose of Covaxin on children between the age of 2-6 years at the All India Institute of Medical Sciences (AIIMS) in New Delhi. The process will begin any time next…

<!-- -->France also announced new rules for entering the country amid a rise in Covid cases.Paris: France will consider people fully vaccinated one week after they received their second dose of the Pfizer/BioNTech, Moderna and…

In what comes as important news for passengers of local trains in Mumbai, the Brihanmumbai Municipal Corporation (BMC) said it is planning to relax restrictions in local trains for those fully vaccinated against the COVID-19 in…

While the Centre has been boasting of an all-time high in terms of jabs provided, Delhi and several others have run out of its stocks for the Covishield vaccine. Delhi’s Deputy Chief Minister, Manish Sisodia tweeted about the shortage as…